Related Experiment Video
Updated: Jun 11, 2025
3D Human Myocardial Tissue Generation Using Melt Electrospinning Writing of Polycaprolactone Scaffolds and hiPSC-Derived Cardiac Cells
Published on: March 28, 2025
Advances in melt electrowriting for cardiovascular applications.
Kilian Maria Arthur Mueller1, Salma Mansi1, Elena M De-Juan-Pardo2,3,4
1Technical University of Munich, TUM School of Engineering and Design, Department of Mechanical Engineering, Chair of Medical Materials and Implants, Munich Institute of Biomedical Engineering (MIBE), Munich Institute of Integrated Materials, Energy and Process Engineering (MEP), Munich, Germany.
Melt electrowriting (MEW) advances biofabrication for cardiovascular tissue engineering. This technique enables microvascular networks, vascular grafts, cardiac tissue scaffolds, and regenerative heart valves, paving the way for clinical translation.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Melt electrowriting (MEW) is an electric-field-assisted additive biofabrication technique.
- MEW offers targeted microfiber placement for bioinspired scaffold design.
- It is a powerful platform for in vitro disease models and in vivo functional biohybrid constructs.
Purpose of the Study:
- To provide a concise overview of MEW's contributions to cardiovascular tissue engineering.
- To highlight advancements in scaffold design for various cardiovascular applications.
- To discuss future challenges and opportunities for MEW technology.
Main Methods:
- Review of key contributions of MEW in cardiovascular tissue engineering.
- Focus on methods for introducing microvascular networks using sacrificial MEW microfibers.
- Exploration of MEW-based concepts for vascular grafts, stents, cardiac tissues, and heart valves.
Main Results:
- MEW facilitates the creation of microvascular networks within 3D constructs.
- MEW-based concepts are reported for small-diameter vascular grafts and stents.
- Tunable MEW scaffolds benefit contracting cardiac tissues and enable complex heart valve architectures.
Conclusions:
- MEW is a transformative technology for cardiovascular tissue engineering.
- It enables the fabrication of complex, functional cardiovascular constructs.
- Addressing technological challenges will unlock MEW's full potential for clinical translation.
